en

PRODUCT DETAIL

Rosazimib 40 mg/10 mg filmom obalené tablety

Code 0310D
MA number 31/0015/19-S
Product Form: tbl flm 30x40 mg/10 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BA Combinations of various lipid modifying agents
C10BA06 Rosuvastatin and ezetimibe
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 25.01.2019
Validity: 25.01.2024
MA renewed: Renewal application submitted
PIL: PIL_Rosazimib tbl flm_07.2023.pdf  
SPC: SPC_Rosazimib tbl flm_07.2023.pdf  
Safety feature Yes
Data update: 15.02.2022
eu-flag.png sk-flag.png